BBK Worldwide is introducing a Patient Recruitment Franchise Program. BBK’s flagship product for its new program is the FRANCHISE e-BINDERSM: a communication platform that uses the Apple iPad® to facilitate the myriad processes necessary to effectively recruit and manage patients for global clinical trials.
This new franchise model supports quick, efficient enrollment for multiple studies within the same therapeutic category, as well as multiple protocols for a single compound. “Franchise programs create savings through the economies of scale derived from applying strategies and tactics across multiple studies and countries,” said Joan F. Bachenheimer, BBK Worldwide founding principal and CEO. “Using the model of the Patient Recruitment Franchise Program, sponsors are able to consolidate planning and recruitment strategies for immediate and long-term cost reductions.”
The Apple iPad supports franchise-level initiatives by making it possible to instantly distribute, store, and retrieve information and data with the tap of a finger. “BBK’s application of this new technology skillfully supports clinical research professionals as they work to manage the avalanche of information surrounding clinical trial particulars,” said Matthew Stumm, BBK Worldwide creative director. Consider the following audience-specific applications of the FRANCHISE e-BINDER, powered by BBK partner company TCN e-Systems:
· Investigator meetings made simple
· Top-level data sourced and easily retrieved for clinical operations
· The STUDY MANAGER e-BINDERSM offers one-stop access to critical forms, inclusion/exclusion criteria, patient materials, etc.Can be adapted for any country/language.
· The UPDATE e-BINDERSM for clinical study managers and monitors provides a hand-held portal to site administration resources – including training, study contact listings, sponsor documentation, clinical assessment tools
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.